Food poisoning, deciphering genetic material, tattoo ink and new non-animal testing methods in risk assessment: These are four of the current scientific topics that will be discussed during a visit by a delegation from the US Food and Drug Administration (FDA) on May 9, 2022 to the German Federal Institute for Risk Assessment (BfR) in Berlin. A cooperation agreement has existed between the two institutions since August 2021. In addition to discussing currently important topics, today's kick-off meeting is about defining priority joint working areas and planning further cooperation. "Health risks from food do not recognise national borders," says BfR President Prof. Andreas Hensel. "For this reason, we are particular pleased to have the FDA, an important pioneer of international consumer protection, as our partner."
Regular exchanges between the two institutions, joint reports and the creation of networks are all planned. Cooperation has been envisaged for the long-term. An initial delegation visit took place in September 2021, and we have already held video conferences and discussions on several scientific topics in the field of consumer health protection.
About the BfR
The German Federal Institute for Risk Assessment (BfR) is a scientifically independent institution within the portfolio of the Federal Ministry of Food and Agriculture (BMEL) in Germany. The BfR advises the Federal Government and the States '‘Laender') on questions of food, chemicals and product safety. The BfR conducts independent research on topics that are closely linked to its assessment tasks.